Pharmaceutical Technology E-Alert:
Having trouble viewing this e-mail? Click here.
You are subscribed to %%list.name%% as %%emailaddr%%.
Click here to unsubscribe or edit your member profile.
  Pharmaceutical Technology Europe E-Alert
 
12 November 2010
IN THIS ISSUE
Sanofi and Genzyme
ODT market value
FDA activities questioned
PTE November
 
Sanofi and Genzyme still at war
Sanofi-aventis has told Genzyme to stand aside and let the shareholders decide on whether an acquisition should take place. More...
 
ODT market to exceed $13 billion by 2015
The market for orally disintegrating and fast dissolving tablets could exceed revenues of $13 billion by 2015 based on upward global growth trends, according to a report from Technology Catalysts. More...
 
Lawmakers question the activities of FDA's Puerto Rico office
The FDA’s Puerto Rico district office “may be having difficulty exercising oversight on the numerous pharmaceutical manufacturing facilities on the island,” according to the chair of the US House of Representatives Committee on Oversight and Government Reform. More...
 
Latest PTE issue available online
Have you read the latest issue of PTE yet? The November issue features articles on dissolution testing for inhaled drugs and scaling up lyophilisation processes, as well as a special feature on pharmaceutical packaging. More...
 
EMA issues draft principles on post-approval change management
The European Medicines Agency (EMA) has published a draft list of questions and answers on post-approval change-management protocols, which is meant to outline the general principles for using and implementing the protocols. More...
 
Biogen Idec announces restructuring programme
Biogen Idec has announced a major restructuring program that will refocus the company’s R&D programs, consolidate facilities and reduce its workforce. More...
 
Join our community on LinkedIn
Want to discuss any of this week’s news stories or any other hot topics in the industry? Then why not join our group on LinkedIn? More...

Latest blog posts
Indian-US trade relations: a delicate balance
Of genes, coal and the US government
Q&A with Systech and Marchesini about Pack Expo 2010
More blog posts

Latest articles
Overcoming the challenges of cell-based bioprocessing
Will transatlantic regulatory cooperation meet expectations?
Orally disintegrating tablets using starch and fructose
More articles

Upcoming events
Chemspec Middle East (29–30 November | UAE)
9th Annual World Drug Manufacturing Summit (30 November–2 December | Germany)
Global Suppler & Partnership Management (1–2 December | Germany)
More events

Product Profiles
Harmonized Culture Media for MLT

Oxoid and Remel, the world leading microbiology brands of Thermo Fisher Scientific, have introduced a complete portfolio of culture media for the microbiological examination of non sterile pharmaceutical products, as recommended in the Harmonized Microbial Limit Tests chapters in the Ph. Eur, USP and JP (current editions).
Read more...

Recruitment Profile
Council of Europe
Vacancy notice(1) for a selection procedure open to nationals of Council of Europe member states.
Read more...


Vacancy notice(2) for a selection procedure open to nationals of Council of Europe member states.

Read more...

Recruitment Profile
Chemspec Middle East

placeholder

29-30 November 2010, Dubai, UAE
Dubai World Trade Centre

The region’s first fine and speciality chemicals event, Chemspec Middle East is part of a natural progression for the Chemspec Events brand as the Gulf region continues to develop in many industries beyond its traditional oil, gas and petrochemical sectors.

Read more...

 



Survey
FDA Commissioner Hamburg recently discussed the creation of user fees for the generic-drug sector. Do you support the proposal?
Yes
No

This week we would like to know...

Do you feel there is a need for stringent regulations relating to excipients for pharmaceutical use?

Click here to vote

Contact Us
Click here to contact editorial.

Click here to contact sales.

 
You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact
information available to third parties for marketing purposes, please contact us by emailing [email protected] or by mail
at Advanstar Communications Inc., Advanstar House, Park West, Sealand Road, Chester, CH1 4RN United Kingdom